View drug registration information details.
Items | Registration information |
ID | 2430 |
No | 2430 |
Brand Name | OMNAPIL-100 |
Ingredients | CEFIXIME (AS TRIHYDRATE) IP EQ.TO CEFIXIME ANHYDROUS 100 MG/5ML |
Dosage Form | POWDER FOR ORAL SUSPENSION |
Primary Packaging | BOTTLE |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 30 ML/BOTTLE |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | FOR THE TREATMENT OF THE FOLLOWING INFECTIONS WHEN CAUSED BY SUSCEPTIBLE ORGANISMS: ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS, COMMUNITY-ACQUIRED PNEUMONIA, LOWER URINARY TRACT INFECTION, PYELONEPHRITIS, OTITIS MEDIA, SINUSITIS, PHARYNGITIS |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | WHITE TO OFF WHITE GRANULAR POWDER FILLED IN CLEAR USP TYPE III, GLASS BOTTLE HAVING YELLOW COLOR SUSPENSION AFTER RECONSTITUTION |
Note | |
License Owner | THC SOLE CO.,LTD |
Manufacturer | PSYCHOTROPICS INDIA LIMITED |
Country | INDIA |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 04 I 4928/20 |
FDD Registration Date | 11-DEC-2023 |
Expiry Date | 10-DEC-2026 |
Back to drug list
|